Skip to content
10-Q

Quarterly Report

FORMA THERAPEUTICS HOLDINGS, INC.

0001564590-21-044302

← back to feed
Filed
Aug 13, 2021 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2021 · Aug 10, 2021 47.39M sh
Current Liabilities Q2 2021 · Jun 30, 2021 $31.1M
Current Liabilities Q2 2021 · Dec 31, 2020 $31.7M
Total Liabilities Q2 2021 · Jun 30, 2021 $33.97M
Total Liabilities Q2 2021 · Dec 31, 2020 $32.73M
Current Assets Q2 2021 · Jun 30, 2021 $557.92M
Current Assets Q2 2021 · Dec 31, 2020 $654.45M
Total Assets Q2 2021 · Jun 30, 2021 $613.37M
Total Assets Q2 2021 · Dec 31, 2020 $680.97M
Cash And Equivalents Q2 2021 · Dec 31, 2020 $282.69M
Cash And Equivalents Q2 2021 · Jun 30, 2020 $374.95M
Stock Issued Q2 2021 · Dec 15, 2020 795K sh
Capex Q2 2021 · Jun 30, 2020 $103K
Operating Cash Flow Q2 2021 · Jun 30, 2020 −$56.83M
Stockholders Equity Q2 2021 · Jun 30, 2020 $438.5M
Stockholders Equity Q2 2021 · Mar 31, 2020 $28.77M
Stockholders Equity Q2 2021 · Dec 31, 2019 $18.25M
Sga Expense Q2 2021 · Jun 30, 2020 $6.45M
Sga Expense Q2 2021 · Jun 30, 2020 $15.38M
Rd Expense Q2 2021 · Jun 30, 2020 $20.51M
Rd Expense Q2 2021 · Jun 30, 2020 $43.72M
Net Income Q2 2021 · Jun 30, 2020 −$25.44M
Net Income Q2 2021 · Jun 30, 2020 −$14.21M
Net Income Q2 2021 · Mar 31, 2020 $11.23M
Operating Income Q2 2021 · Jun 30, 2020 −$26.94M
Operating Income Q2 2021 · Jun 30, 2020 −$59.17M